EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. – Alnylam Pharmaceuticals, Inc. Transaction History
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:
$5.75M
portfolio value
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +7.00% | 1.88K shares | 1.83M | $200.16 | 28.75K |
| Q2 2022 | share | Decrease | -31.44% | -12.32K shares | -2.48M | $145.85 | 26.87K |
| Q1 2022 | share | Increase | 0.00% | 39.19K shares | 6.40M | $163.29 | 39.19K |